Immutep IMMP
NASDAQ IMMP
$3.26 +0.03 (+0.77%)
As of: Oct 21, 2026 · 3:25 PM EDT

Immutep (IMMP) EBIT Margin (2014 - 2017)

Updated

Immutep (IMMP) reported EBIT Margin of -545.26% for the year ended Jun 30, 2026, up 49.74 percentage points from -595.00% a year earlier.

Analysis

Immutep (IMMP) EBIT Margin (2014 - 2017) Analysis & Trends

Dating back to the year ended Jun 30, 2010, Immutep's EBIT Margin record includes 13 years.

  • EBIT Margin has a four-year change of +18415.48 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 ranks as the highest annual EBIT Margin since the year ended Jun 30, 2020.
  • According to Business Quant data, EBIT Margin came in at -595.00% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Immutep 23.69 Mn -187.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -370.98%
Mar 31, 2017 -137.35%
Jun 30, 2016 3,420,144.49%
Mar 31, 2016 -763.62%
Jun 30, 2015 -19,635.70%
Jun 30, 2014 -83,682.43%
API Access

Immutep EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY